Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Psychopharmacology|June 11, 2010
Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) ratsAmir H Rezvani, Susan Slade, Cori Wells, et al.Molecular Cancer Therapeutics|April 18, 2009
AMP-activated protein kinase promotes human prostate cancer cell growth and survivalHyeon Ung Park, Simeng Suy, Malika Danner, et al.Journal of Medicinal Chemistry|April 2, 2013
Chemistry and pharmacological studies of 3-alkoxy-2,5-disubstituted-pyridinyl compounds as novel selective α4β2 nicotinic acetylcholine receptor ligands that reduce alcohol intake in ratsYong Liu, Janell Richardson, Thao Tran, et al.Cancer Biology & Therapy|September 3, 2011
VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cellsLymor Ringer, Paul Sirajuddin, Mary Heckler, et al.Neuropharmacology|December 19, 2006
A pharmacophore derived phenytoin analogue with increased affinity for slow inactivated sodium channels exhibits a desired anticonvulsant profilePaul W Lenkowski, Timothy W Batts, Misty D Smith, et al.Bioorganic & Medicinal Chemistry|February 28, 2012
Asymmetric synthesis and evaluation of a hydroxyphenylamide voltage-gated sodium channel blocker in human prostate cancer xenograftsGary C Davis, Yali Kong, Mikell Paige, et al.Chemistry & Biology|October 27, 2007
Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbetaMichael J Gorczynski, Jolanta Grembecka, Yunpeng Zhou, et al.Journal of Medicinal Chemistry|September 20, 2013
Design, synthesis and discovery of picomolar selective α4β2 nicotinic acetylcholine receptor ligandsVenkata M Yenugonda, Yingxian Xiao, Edward D Levin, et al.Oncotarget|March 3, 2012
Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1Julie S Barber-Rotenberg, Saravana P Selvanathan, Yali Kong, et al.Pageof 9